5.47  0.04 (0.74%)		05-14 16:00
Open: 5.4 High: 5.62 Volume: 934,649		Pre. Close: 5.43 Low: 5.38 Market Cap: 473(M)

Short term
Mid term
Targets	6-month :	6.79	1-year :	7.93
Resists	First :	5.82	Second :	6.79
Pivot price	5.19
Supports	First :	4.66	Second :	3.95
MAs	MA(5) :	5.51	MA(20) :	5.07
	MA(100) :	4.81	MA(250) :	4.58
MACD	MACD :	0.2	Signal :	0.2
%K %D	K(14,3) :	67.2	D(3) :	74.8
RSI	RSI(14): 64
52-week	High :	6.01	Low :	3.3

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SRTA ] has closed below upper band by 24.8%. Bollinger Bands are 8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	5.62 - 5.65	5.65 - 5.68
Low:	5.32 - 5.34	5.34 - 5.37
Close:	5.42 - 5.47	5.47 - 5.51

Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Wed, 13 May 2026
Insider Sell Alert: Amir Cohen Sells Shares of Strata Critical M - GuruFocus

Fri, 08 May 2026
1.58M Strata Critical (SRTA) warrants expire worthless - Stock Titan

Fri, 08 May 2026
Strata Critical Medical, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st

Thu, 07 May 2026
Strata Critical Medical Announces Expiration of Warrants - GlobeNewswire

Wed, 06 May 2026
Strata Critical Medical, Inc. 1Q 2026: Revenue $67.38M, EPS $0.03— 10-Q Summary - TradingView

Wed, 06 May 2026
STRATA CRITICAL MEDICAL ($SRTA) Releases Q1 2026 Earnings - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Industrials
Industry: Airlines, Airports & Air Services
Shares Out	86 (M)
Shares Float	62 (M)
Held by Insiders	14 (%)
Held by Institutions	75 (%)
Shares Short	5,910 (K)
Shares Short P.Month	6,580 (K)

EPS	-0.24
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.22
Profit Margin	20.9 %
Operating Margin	-5.4 %
Return on Assets (ttm)	-2.8 %
Return on Equity (ttm)	-8.1 %
Qtrly Rev. Growth	83.5 %
Gross Profit (p.s.)	0.47
Sales Per Share	2.28
EBITDA (p.s.)	-0.07
Qtrly Earnings Growth	0 %
Operating Cash Flow	-49 (M)
Levered Free Cash Flow	-27 (M)

PE Ratio	-22.8
PEG Ratio	0
Price to Book value	1.69
Price to Sales	2.39
Price to Cash Flow	-9.67

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.